Related Experiment Videos
Suloctidil therapy in migraine: an open pilot study
Current Medical Research and Opinion
|January 1, 1983
Summary
Suloctidil showed potential in a pilot study for severe migraine patients unresponsive to other drugs. Over half experienced good or significant improvement in migraine frequency with daily prophylactic treatment.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a debilitating neurological condition.
- Many patients with severe, frequent migraines do not respond adequately to existing drug therapies.
- There is a need for effective prophylactic treatments for refractory migraine.
Purpose of the Study:
- To assess the effectiveness of suloctidil as a prophylactic treatment for severe and frequent migraine attacks.
- To evaluate the tolerance and side-effect profile of suloctidil in this patient population.
Main Methods:
- An open pilot study was conducted.
- 27 patients with severe and frequent migraine attacks were enrolled.
- Patients received 600 mg of suloctidil daily for 6 weeks.
Main Results:
- Good response (reduction in attack frequency) was observed in 7 patients.
- Significant improvement was noted in 11 patients.
- 9 patients showed doubtful or no effectiveness; one patient discontinued due to adverse reactions, and 10 reported mild side-effects.
Conclusions:
- Suloctidil demonstrated potential effectiveness in a subset of patients with severe, refractory migraine.
- The drug was generally well-tolerated, with mostly mild side-effects reported.
- Further investigation in larger, controlled trials is warranted to confirm these findings.